The efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone in patients with androgen-independent prostate cancer: a systematic review

The aim of this systematic review was taken to investigate the efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone for treating androgen-independent prostate cancer (AIPC). Data were collected from different databases independently by three researchers according to the pre-defined...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Long, Qiu, Xianxin, Wang, Rixiong, Xie, Xianhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381221/
https://www.ncbi.nlm.nih.gov/pubmed/24769540
http://dx.doi.org/10.1038/srep04818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381221/
https://www.ncbi.nlm.nih.gov/pubmed/24769540
http://dx.doi.org/10.1038/srep04818

Ejemplares similares